|
[1]
|
Preferential meropenem absorption activated by 1α,25-dihydroxyvitamin D3 and shared with foscarnet, a phosphate transporter substrate, in the rat ileum
Drug Metabolism and Pharmacokinetics,
2024
DOI:10.1016/j.dmpk.2024.100997
|
|
|
|
|
[2]
|
Liquid CO2 Formulated Mesoporous Silica Nanoparticles for pH-Responsive Oral Delivery of Meropenem
ACS Biomaterials Science & Engineering,
2021
DOI:10.1021/acsbiomaterials.0c01284
|
|
|
|
|
[3]
|
Microfluidic assembly of pomegranate-like hierarchical microspheres for efflux regulation in oral drug delivery
Acta Biomaterialia,
2021
DOI:10.1016/j.actbio.2021.03.042
|
|
|
|
|
[4]
|
Physiologically Based Pharmacokinetic Modeling of Meropenem in Preterm and Term Infants
Clinical Pharmacokinetics,
2021
DOI:10.1007/s40262-021-01046-6
|
|
|
|
|
[5]
|
PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery
International Journal of Pharmaceutics,
2021
DOI:10.1016/j.ijpharm.2021.120280
|
|
|
|
|
[6]
|
PLGA encapsulated γ-cyclodextrin-meropenem inclusion complex formulation for oral delivery
International Journal of Pharmaceutics,
2021
DOI:10.1016/j.ijpharm.2021.120280
|
|
|
|
|
[7]
|
Liquid CO2 Formulated Mesoporous Silica Nanoparticles for pH-Responsive Oral Delivery of Meropenem
ACS Biomaterials Science & Engineering,
2021
DOI:10.1021/acsbiomaterials.0c01284
|
|
|
|
|
[8]
|
The Case for Intermittent Carbapenem Dosing in Stable Haemodialysis Patients
Antibiotics,
2020
DOI:10.3390/antibiotics9110815
|
|
|
|
|
[9]
|
Oral meropenem for superbugs: challenges and opportunities
Drug Discovery Today,
2020
DOI:10.1016/j.drudis.2020.11.004
|
|
|
|
|
[10]
|
Solid nanoparticles for oral antimicrobial drug delivery: a review
Drug Discovery Today,
2019
DOI:10.1016/j.drudis.2019.01.004
|
|
|
|
|
[11]
|
Effect of Antibiotics on Gut Microbiota, Gut Hormones and Glucose Metabolism
PLOS ONE,
2015
DOI:10.1371/journal.pone.0142352
|
|
|
|
|
[12]
|
Synthesis, pH-dependent, and plasma stability of meropenem prodrugs for potential use against drug-resistant tuberculosis
Bioorganic & Medicinal Chemistry,
2013
DOI:10.1016/j.bmc.2013.05.024
|
|
|
|